Get the Stockscreener App
1.95
3.17%
0.06
Grace Therapeutics Inc Stock (GRCE) Forecast
The Grace Therapeutics Inc (GRCE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.631, representing a +34.92% increase from the current price of $1.95. The highest analyst price target is $3.6827, and the lowest is $1.5792.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GRCE Price Target
Average 2.1215
(+8.79% Upside)
Is Grace Therapeutics Inc (GRCE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.72 | Neutral |
| STOCH(9,6) | 29.37 | Neutral |
| STOCHRSI(14) | 38.04 | Neutral |
| MACD(12,26) | -0.0502 | Sell |
| ADX(14) | 16.26 | Neutral |
| William %R | -66.90 | Neutral |
| CCI(14) | -114.64 | Sell |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.0265
Sell
|
2.0131
Sell
|
| MA20 |
2.0718
Sell
|
2.0572
Sell
|
| MA50 |
2.1205
Sell
|
2.1377
Sell
|
| MA100 |
2.2314
Sell
|
2.3221
Sell
|
| MA200 |
2.9113
Sell
|
2.5928
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, GRCE could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 12 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on GRCE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.72 indicates that GRCE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.37 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.04 indicates that GRCE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.26 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -114.64 indicates that GRCE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term GRCE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Grace Therapeutics Inc financial reports and earnings history, Grace Therapeutics Inc (GRCE) stock could reach $1.0408 by 2030, $2.601 by 2040 and $8.5856 by 2050. See the projected annual prices until 2050 of the Grace Therapeutics Inc stock below:
- Grace Therapeutics Inc (GRCE) is expected to reach an average price of $0.0966 in 2035, with a high prediction of $1.4749 and a low estimate of $0.402. This indicates an $-95.04% rise from the last recorded price of $1.95.
- Grace Therapeutics Inc (GRCE) stock is projected to chart a bullish course in 2040, with an average price target of $2.6555, representing an $36.18% surge from its current level. The forecast ranges from a conservative $2.6645 to a sky-high $2.601.
- Our analysts predict Grace Therapeutics Inc (GRCE) to jump 347.60% by 2045, soaring from $8.5714 to an average price of $8.7283, potentially reaching $8.5682. While $8.5714 is the low estimate, the potential upside is significant.
- Grace Therapeutics Inc (GRCE) stock is expected to climb by 2050, reaching an average of $8.588, a $340.41% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.5856 and $8.633, respectively, highlighting the market's uncertainty.
Grace Therapeutics Inc Stock (GRCE) Year by Year Forecast
Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2026
The predicted value for Grace Therapeutics Inc (GRCE) in 2026 is set at an average of $3.3796. Estimates vary from a peak of $5.18 to a trough of $1.5792, indicating an +73.31% surge from the present price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $3.2177 | $1.5792 | $3.6827 | +65.01% |
| December, 2026 | $2.4762 | $2.1016 | $3.1825 | +26.99% |
Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Grace Therapeutics Inc (GRCE) is $1.9953, with a high forecast of $3.4305 and a low forecast of $0.5602. This indicates an +2.33% increase from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6547 | $2.0501 | $3.4305 | +36.14% |
| February, 2027 | $2.0632 | $1.6686 | $2.6593 | +5.81% |
| March, 2027 | $1.1163 | $0.8571 | $2.0678 | -42.75% |
| April, 2027 | $0.9048 | $0.5602 | $1.2056 | -53.60% |
| May, 2027 | $1.6379 | $0.8294 | $1.9733 | -16.00% |
| June, 2027 | $1.6964 | $1.6113 | $2.1564 | -13.00% |
| July, 2027 | $2.0049 | $1.6911 | $2.0399 | +2.82% |
| August, 2027 | $1.768 | $1.708 | $2.6215 | -9.33% |
| September, 2027 | $1.9465 | $1.7027 | $2.3119 | -0.18% |
| October, 2027 | $2.025 | $1.8512 | $2.2658 | +3.85% |
| November, 2027 | $2.1011 | $1.8496 | $2.3581 | +7.75% |
| December, 2027 | $2.1666 | $1.9174 | $2.2666 | +11.11% |
Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2028
In 2028, Grace Therapeutics Inc (GRCE) is projected to reach an average price of $2.5657, with a high projection of $4.2537 and a low estimate of $0.8776. This indicates an +31.57% rise from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.3997 | $2.0659 | $2.6724 | +23.06% |
| February, 2028 | $2.6682 | $2.3644 | $2.9336 | +36.83% |
| March, 2028 | $2.6467 | $2.4229 | $2.9609 | +35.73% |
| April, 2028 | $3.2552 | $2.6306 | $3.7052 | +66.93% |
| May, 2028 | $2.6683 | $1.5783 | $4.2537 | +36.84% |
| June, 2028 | $1.4368 | $0.8776 | $4.1476 | -26.32% |
| July, 2028 | $1.4199 | $1.1907 | $1.8299 | -27.18% |
| August, 2028 | $1.4084 | $1.2166 | $1.6187 | -27.77% |
| September, 2028 | $1.4869 | $1.3631 | $1.7277 | -23.75% |
| October, 2028 | $1.3001 | $1.0116 | $1.6015 | -33.33% |
| November, 2028 | $1.3085 | $1.2439 | $1.6539 | -32.90% |
| December, 2028 | $1.297 | $1.1924 | $1.3832 | -33.49% |
Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2029
The 2029 price forecast for Grace Therapeutics Inc Stock (GRCE) is $1.2093 on average, with a high prediction of $2.4005 and a low estimate of $0.0181. This represents an -37.98% decrease from the previous price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5177 | $0.2785 | $1.2817 | -73.45% |
| February, 2029 | $1.0247 | $0.427 | $2.4005 | -47.45% |
| March, 2029 | $1.4817 | $0.8332 | $1.6717 | -24.01% |
| April, 2029 | $0.7679 | $0.4687 | $2.176 | -60.62% |
| May, 2029 | $0.1049 | $0.0351 | $1.2472 | -94.62% |
| June, 2029 | $0.1181 | $0.1473 | $0.2858 | -93.94% |
| July, 2029 | $0.2581 | $0.0181 | $0.2581 | -86.76% |
| August, 2029 | $0.6551 | $0.2759 | $0.8066 | -66.40% |
| September, 2029 | $0.7221 | $0.4631 | $1.0129 | -62.97% |
| October, 2029 | $1.1283 | $0.6314 | $1.5056 | -42.14% |
| November, 2029 | $1.0253 | $0.6053 | $1.2676 | -47.42% |
| December, 2029 | $1.0016 | $0.7431 | $1.2238 | -48.64% |
Grace Therapeutics Inc Stock (GRCE) Price Forecast for 2030
Grace Therapeutics Inc Stock (GRCE) is expected to reach an average price of $1.6811 in 2030, with a high forecast of $3.3274 and a low forecast of $0.0348. This signifies an -13.79% decrease from the last price of $1.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.9135 | $0.7893 | $1.0408 | -53.15% |
| February, 2030 | $1.0805 | $0.857 | $1.3163 | -44.59% |
| March, 2030 | $1.1425 | $0.8848 | $1.2433 | -41.41% |
| April, 2030 | $1.4687 | $1.0518 | $1.6722 | -24.68% |
| May, 2030 | $1.8657 | $1.4457 | $1.9837 | -4.32% |
| June, 2030 | $1.9627 | $1.505 | $2.1827 | +0.65% |
| July, 2030 | $2.7989 | $1.6812 | $3.0689 | +43.54% |
| August, 2030 | $2.7659 | $0.6567 | $3.3274 | +41.84% |
| September, 2030 | $0.3722 | $0.0348 | $3.2352 | -80.91% |
| October, 2030 | $0.4491 | $0.3014 | $0.9499 | -76.97% |
| November, 2030 | $0.6561 | $0.3551 | $0.7525 | -66.35% |
| December, 2030 | $0.4624 | $0.1731 | $0.8754 | -76.29% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):